3,238 results on '"bosentan"'
Search Results
2. Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
3. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
4. Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
5. Endothelin Receptor Function and Acute Stress (End-Stress)
6. Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.
7. Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1 (UMMC_Pilot)
8. Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension (MoD)
9. The Anti-Atherosclerotic Effects of Endothelin Receptor Antagonist, Bosentan, in Combination with Atorvastatin—An Experimental Study.
10. Simple Determination of Bosentan in Plasma Samples by Reversed-Phase High-Performance Liquid Chromatography.
11. In vivo assessment, formulation, characterization and enhancing pharmacotherapy of encapsulated mini tablets for immediate release Sildenafil citrate and sustained release Bosentan
12. Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)
13. Microfabricated potentiometric sensor based on a carbon nanotube transducer layer for selective Bosentan determination
14. A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
15. Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study.
16. Bosentan and ambrisentan in the treatment of idiopathic pulmonary fibrosis: a meta-analysis.
17. Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
18. Safety of Bosentan in Type II Diabetic Patients (BOSRET)
19. Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1.
20. Kids Mod PAH trial: A multicenter trial comparing mono-versus duo-therapy for initial treatment of pediatric pulmonary hypertension.
21. ENDOTHELION Study Group: Effect of Bosentan in NAION Patients (ENDOTHELION)
22. The protective effect of bosentan on methotrexate-induced oral mucositis in rats
23. SOCIAL INSURANCE FUND invites tenders for Small Amount Tender no 1000997669-08-31 Bosentan 125Mg, Film-Coated Tablet, Oral Use, Ctni 106108, i Call
24. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Order 3062/2024 Code 1367 Bosentan, Tablet 125 Mg. Amparo No. 01021-2016-00061. *Uses*
25. HOSPITAL GUILLERMO GRANT BENAVENTE DE CO invites tenders for Bosentan Convention and Others
26. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Igss Code 1,367 Bosentan Tablet 125 Mg. Application: 3174/2024
27. The Anti-Atherosclerotic Effects of Endothelin Receptor Antagonist, Bosentan, in Combination with Atorvastatin—An Experimental Study
28. Solubility of Bosentan in Polyethylene Glycol 400 + Water Mixtures: Experimental and Mathematical Computations
29. Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension.
30. Kids Mod PAH trial: A multicenter trial comparing mono‐ versus duo‐therapy for initial treatment of pediatric pulmonary hypertension
31. High energy ball milling vs. nano spray drying in the development of supersaturated systems loaded with bosentan.
32. Pharmacogenomics in Pulmonary Arterial Hypertension
33. Reflex Responses to Intermittent Hypoxia in Humans: Mechanisms and Consequences
34. Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors
35. Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study
36. Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
37. AIRA Pharm GmbH secures contract for Pharmaceutical Products - Bosentan 62.5 Mg Film-Coated Tablets St
38. AIRA Pharm GmbH secures contract for Pharmaceutical Products - Bosentan 125 Mg Film-Coated Tablets St
39. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Code 1367 Bosentan Tablet 125 Mg
40. SOCIAL INSURANCE FUND invites tenders for Small Amount Public Tender no 1000987896-08-31, Ira Call, Bosentan 125Mg, Film-Coated Tablet, Oral Use., C.T.N.I.: 106108
41. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Igss Code 1,367 Bosentan Tablet 125 Mg. Application: 2865/2024
42. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Igss Code: 1367, Bosentan, Tablet 125 Mg. P-6562
43. BRANCH NO. 1 GKU AZ (KS) DZM invites tenders for Supply of a Medicinal Product (Bosentan (Tn: Tracleer Dt)) to Provide the Patient Based on the Decision of the Medical Commission (Unz: Z2421195)
44. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Order 79, Igss Code 1367, Bosentan, Tablet 125 Mg
45. Real‐world effectiveness and safety of bosentan in Japanese patients with systemic sclerosis: A single‐center retrospective study.
46. Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants
47. FUTURE 3 Study Extension (FUTURE 3 Ext)
48. Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
49. Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
50. Endothelin-1 Induces Cell Proliferation and Myofibroblast Differentiation through the ET A R/G αq /ERK Signaling Pathway in Human Cardiac Fibroblasts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.